Left ventricle relative wall thickness and plasma leptin levels: Baseline relationships and effects of 4 months of walking training in healthy overweight postmenopausal women

Menopause

Volumn 18, Issue 1, 2011, Pages 77-84

  Di Blasio, Andrea ^a   Di Donato, Francesco ^a   De Stefano, Angela ^b   Gallina, Sabina ^a   Granieri, Monica ^c   Napolitano, Giorgio ^a   Petrella, Vittorio ^d   Riccardi, Irene ^c   Santarelli, Francesco ^c   Valentini, Pasquale ^e   Ripari, Patrizio ^a,b  

^a Department of Human Movement Science ^*  (France)

^b University Centre of Sports Medicine   (France)

^c Postgraduate School of Cardiology   (United States)

^d Postgraduate School of Endocrinology   (United States)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

Left ventricle relative wall thickness; Leptin; Postmenopause; Walking training.

Indexed keywords

LEPTIN;

ADULT; AEROBIC EXERCISE; ANTHROPOMETRY; ARTICLE; DIET; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HUMAN; MAJOR CLINICAL STUDY; OBESITY; OXYGEN CONSUMPTION; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SKINFOLD; WALKING;

BODY MASS INDEX; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART VENTRICLES; HUMANS; LEPTIN; MIDDLE AGED; MYOCARDIUM; OVERWEIGHT; POSTMENOPAUSE; SKINFOLD THICKNESS; WALKING;

EID: 78651408944     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181e57813     Document Type: Article

References (53)

1. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1105-1110.
2. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease: the Framingham Study. Ann Intern Med 1978; 89:157-161.
3. Stangl V, Baumann G, Stangl K. Coronary atherogenic risk factors in women. Eur Heart J 2002;23:1738-1752.
4. Kopelman PG. Obesity as medical problem. Nature 2000;404:635-643.
5. Yudkin JS. Adipose tissue, insulin action and vascular disease: inflammatory signals. Int J Obes Relat Metab Disord 2003;27:525-528.
6. Karason K, Sjostrom L, Wallentin I, Peltonen M. Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure. Eur Heart J 2003;24:1500-1505.
7. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
8. Ruhl CE, Everhart JE. Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr 2001;74:295-301.
9. Jequier E, Tappy L. Regulation of body weight in humans. Physiol Rev 1999;79:451-480.
10. Sihna MK, Caro JF. Clinical aspects of leptin. Vitam Horm 1998;54:1-30.
11. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546-549.
12. Pelleymounter MA, Cullen MJ, Baker MB, et al. Effects of the obese gene product on body weight regulation on ob/ob mice. Science 1995; 269:540-543.
13. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006;443:289-295.
14. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptormediated regional sympathetic nerve activation by leptin. J Clin Invest 1997;100:270-278.
15. Harvey J. Leptin: a diverse regulator of neuronal function. J Neurochem 2007;100:307-313.
16. Harvey J, Solovyova N, Irving A. Leptin and its role in hippocampal synaptic plasticity. Prog Lipid Res 2006;45:369-378.
17. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science 1998;281:1683-1686.
18. Bouloumie A, Drexler HC, Lafontan M, Busse R. Leptin, the product of ob gene, promotes angiogenesis. Circ Res 1998;83:1059-1066.
19. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000; 100:197-207.
20. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996;12:318-320.
21. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvationinduced immunosuppression. Nature 1998;394:897-901.
22. Howard JK, Lord GM, Matarese G, et al. Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice. J Clin Invest 1999;104:1051-1059.
23. Lam QLK, Lu L. Role of leptin in immunity. Cell Mol Immunol 2007; 4:1-13.
24. Rajapurohitam V, Gan XT, Kirshenbaum LA, Karmazyn M. The obesityassociated peptide leptin induces hypertrophy in neonatal rat ventricular myocytes. Circ Res 2003;93:277-279. (Pubitemid 37048239)
25. Barouch LA, Berkowitza DE, Harrison RW, O'Donnell CP, Hare JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 2003;108:754-759.
26. Mcgaffin KR, Sun CK, Rager JJ, et al. Leptin signalling reduces the severity of cardiac dysfunction and remodelling after chronic ischaemic injury. Cardiovasc Res 2008;77:54-63.
27. Lieb W, Sullivan LM, Aragam J, et al. Relation of serum leptin with cardiac mass and left atrial dimension in individuals 970 years of age. Am J Cardiol 2009;104:602-605.
28. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987;114: 413-419.
29. Schillaci G, Verdecchia P, Borgioni C, Ciucci A, Porcellati C. Early cardiac changes after menopause. Hypertension 1998;32:764-769.
30. Mehta SK, Rame E, Khera A, et al. Left ventricular hypertrophy, subclinical atherosclerosis and inflammation. Hypertension 2007;49:1385-1391.
31. Hinderliter AL, Sherwood A, Blumenthal JA, et al. Changes in hemodynamics and left ventricular structure after menopause. Am J Cardiol 2002;89:830-833.
32. Malavazos AE, Corsi MM, Ermetici F, et al. Proinflammatory cytokines and cardiac abnormalities in uncomplicated obesity: relationship with abdominal fat deposition. Nutr Metab Cardiovasc Dis 2007;17:294-302.
33. Baumgartner RN. Age. In: Heymsfield SB, Lohman TG, Wang Z, et al, eds. Human Body Composition. Champaign, IL: Human Kinetics, 2005: 259-271.
34. Grinspoon S, Gulick T, Askari H. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 1996;81:3861-3863.
35. Gutin B, Ramsey L, Barbeau T, et al. Plasma leptin concentration in obese children: changes during 4-mo periods with and without physical training. Am Soc Clin Nutr 1999;69:388-394.
36. Stewart KJ, Ouyang P, Bacher AC, Lima S, Shapiro EP. Exercise effects on cardiac size and left ventricular diastolic function: relationships to changes in fitness, fatness, blood pressure and insulin resistance. Heart 2006;92:893-898.
37. Warburton DER, Nicol CW, Bredin SSD. Health benefits of physical activity: the evidence. CMAJ 2006;174:801-809.
38. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription, 7th ed. Baltimore, MD: Lippincott Williams & Wilkins, 2005.
39. Bray GA, Gray DS. Anthropometric measurements in the obese. In: Lohman TG, Roche AF, Martorell R, eds. Anthropometric Standardization Reference Manual. Champaign, IL: Human Kinetics, 1988:131-136.
40. Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysisVpart II: utilization in clinical practice. Clin Nutr 2004;23: 1430-1453.
41. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in human and experimental animals: part 1. Blood pressure measurement in humans. A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005;45:142-161.
42. Mayet J, Ariff B, Wasan B, et al. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy. Hypertension 2000;34:755-759.
43. Deveraux RB, Pini R, Aurigemma GP, Raman MJ. Measurement of left ventricular mass: methodology and expertise. J Hypertens 1997;15: 801-809.
44. Nagueh SF, Mikati I, Kopelen HA, Middleton KJ, Quinones MA, Zoghbi WA. Doppler estimation of left ventricular filling pressure in sinus tachycardia: a new application of tissue Doppler imaging. Circulation 1998;98:1644-1650.
45. Ommen SR, Nishimura RA, Appleton CP, et al. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Dopplercatheterization study. Circulation 2000;102:1788-1794.
46. Kline G, Porcari J, Hintermeister R, et al. Estimation of V? O2max from one-mile track walk, gender, age, and body weight. Med Sci Sports Exerc 1987;19:253-259.
47. Warburton DER, Nicol CW, Bredin SSD. Prescribing exercise as preventive therapy. CMAJ 2006;174:961-974.
48. Heyward VH. Advanced Fitness Assessment and Exercise Prescription, 5th ed. Champaign, IL: Human Kinetics, 2006.
49. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension. Eur Heart J 2007;28:1462-1536.
50. Paolisso G, Tagliamonte MR, Galderisi M, et al. Plasma leptin level is associated with myocardial wall thickness in hypertensive insulinresistant men. Hypertension 1999;34:1047-1052.
51. Xu FP, Chen MS, Wang YZ, et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species, pathway in cultured neonatal rat cardiomyocytes. Circulation 2004;110:1269-1275.
52. Pinieiro R, Iglesias MJ, Eiras S, et al. Leptin does not induce hypertrophy, cell cycle alterations, or production of MCP-1 in cultured rat and mouse cardiomyocytes. Endocr Res 2005;31:375-386.
53. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.